Berry Genomics

IPO

Genomics from preconception to adulthood

Public · Beijing, China · Founded 2010 · $129.8M raised

Headquarters
Beijing
Employees
201–500
Founded
2010
Business Model
B2B
Total Funding
$129.8M
Last Round
$99.2M Series BJan 2020
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Berry Genomics (北京贝瑞和康生物技术有限公司) was founded in May 2010 and is China's leading genomics company. Berry Genomics pioneered the first NGS-based non-invasive prenatal testing (NIPT) in China in 2010, and currently provides genetic test services to over 2,000 hospitals in China. In August 2017, Berry Genomics became the first genomic company to be listed on the main board of China A share exchange (stock code: 000710). The company also founded Berry Oncology in 2017, focusing on cancer early detection and liquid biopsy.

Summary

Berry Genomics is a Healthcare company based in Beijing, China, founded in 2010. It has raised $129.8M in total across 3 rounds, most recently a $99.2M Series B round in Jan 2020. Investors include Qiming VP, Legend Capital and Zhongjin Qichen Industry Equity Investment.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries B2020 (est.)
$99.2M

Sign up to see all 3 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth EquityTotal funding$1.5BApr 2025
Foundation MedicineAcquired

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...

Cambridge, United States1001–5000Diagnostics, Genomics
Corporate RoundTotal funding$1.1BJan 2015
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Function Health

Function Health offers annual lab testing and personalized health insights, helping members track...

Austin, United States201–500Diagnostics, Healthcare
Growth EquityTotal funding$1.1BJul 2026
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Berry Genomics on Indexed.vc
<a href="https://indexed.vc/companies/berry-genomics"><img src="https://indexed.vc/api/badge/company/berry-genomics" alt="Berry Genomics on Indexed.vc" width="260" height="76" /></a>